SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : neog - Neogen's E.Coli Test adopted by Japan
NEOG 6.200+0.6%11:45 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Kramer who wrote (393)3/23/2000 7:38:00 PM
From: Kramer  Read Replies (1) of 441
 
I'm not sure what everyone else is expecting from neog tomorrow, but I'm going to be looking at revenues very closely this time. I'd like to see them back on track with an increase of around 20%. The coverage we got today was welcome and I'm noting the information it provided on Acumedia...Hmmmm...if their numbers are even close, adding in $8-$10 million in Acumedia revenue, WOW that could be big! Big! BIG!!!. And to think that the Vicam case is likely to award neog what they paid for Acumedia!!!! Acumedia for free!! That's sweet!!! I love this country!

On the bottom line I think some of our profits have probably gone up in legal expenses preparing for the trial that starts next Monday. So I'm not going to be looking at the bottom line EPS as much, although I'd like to see that over 10 cents too. And of course did I forget to mention that I'm looking forward to a nice fat juicy award from Vicam??? What vicam did was way out of line and I think any jury will see it to the tune of the policy limits and I'd be surprised if Vicam policy limits are less than $5 million.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext